Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Scott Maul"'
Autor:
Bradley J. Monk, Thomas J. Herzog, George Wang, Spyros Triantos, Scott Maul, Roland Knoblauch, Tracy McGowan, Waleed S.W. Shalaby, Robert L. Coleman
Publikováno v:
Data in Brief, Vol 30, Iss , Pp 105465- (2020)
The data presented herein are supplementary to our published primary article “A phase 3 randomized, open-label, multicenter trial for safety and efficacy of combined trabectedin and pegylated liposomal doxorubicin therapy for recurrent ovarian canc
Externí odkaz:
https://doaj.org/article/3efa6e26300e47cfaf5c6b14c7d74dfb
Autor:
Kim N Chi, Neil Fleshner, Vincenzo Emanuele Chiuri, Siska Van Bruwaene, Jason Hafron, Douglas G McNeel, Peter De Porre, Raymond Scott Maul, Mahesh Daksh, Xiaogang Zhong, Gary E Mason, Ronald F Tutrone
Publikováno v:
The Oncologist. 28:e309-e312
Niraparib (NIRA) is a highly selective inhibitor of poly (adenosine diphosphate-ribose) polymerase, PARP1 and PARP2, which play a role in DNA repair. The phase II QUEST study evaluated NIRA combinations in patients with metastatic castration-resistan
Autor:
Kim Chi, Neil Fleshner, Vincenzo Emanuele Chiuri, Scaranos, Siska Van Bruwaene, Jason Hafron, Douglas G. McNeel, Peter De Porre, R. Scott Maul, Mahesh Daksh, Xiaogang Zhong, Gary E. Mason, Ronald Tutrone
Publikováno v:
Journal of Urology. 207
Autor:
Waleed Shalaby, Scott Maul, Bradley J. Monk, Spyros Triantos, George Wang, Roland Elmar Knoblauch, Thomas J. Herzog, Robert L. Coleman, Tracy McGowan
Publikováno v:
Gynecologic Oncology. 156:535-544
Objective This phase 3 study aimed to compare overall survival (OS) of women with platinum-sensitive, recurrent ovarian cancer (ROC) treated with third-line trabectedin (T) + pegylated liposomal doxorubicin (PLD) vs. PLD monotherapy. Methods Women wi
Autor:
Richard F. Dunne, Judith O. Hopkins, Po-Ju Lin, Javier Bautista, Chunkit Fung, Karen M. Mustian, J. Scott Maul, Kah Poh Loh, Janos Molnar
Publikováno v:
Medicine & Science in Sports & Exercise. 53:477-477
Autor:
Scott Maul, Waleed Shalaby, Robert L. Coleman, Tracy McGowan, Bradley J. Monk, Thomas J. Herzog, George Wang, Roland Elmar Knoblauch, Spyros Triantos
Publikováno v:
Data in Brief
Data in Brief, Vol 30, Iss, Pp 105465-(2020)
Data in Brief, Vol 30, Iss, Pp 105465-(2020)
The data presented herein are supplementary to our published primary article “A phase 3 randomized, open-label, multicenter trial for safety and efficacy of combined trabectedin and pegylated liposomal doxorubicin therapy for recurrent ovarian canc
Autor:
M J Pontes Valero, George Wang, Scott Maul, Waleed Shalaby, Tracy McGowan, Bradley J. Monk, Spyros Triantos, Robert L. Coleman, Thomas J. Herzog
Publikováno v:
Annals of Oncology. 30:v420-v421
Background Retreatment with PLD in ROC has raised potential concerns of increased toxicity and diminished response rates. This subgroup analysis examined the safety and efficacy of platinum-sensitive patients (pts) with prior PLD therapy who particip
Publikováno v:
Polymer Engineering & Science. 53:283-294
In this article, the durability of the interfacial bonds between epoxy and concrete during hygrothermal exposure was investigated. Through the application of a silane coupling agent, we examined the hypothesis that hydrogen bonding plays a large role
Autor:
John Scott Maul, Maharaj Singh, Jennifer Lynn Pogodzinski, Mary Elizabeth Megan, Lauren Ashley Olson
Publikováno v:
Journal of Clinical Oncology. 36:208-208
208 Background: A majority of (80–100%) of patients with cancer report cancer-related fatigue. Physical activity has shown to be an effective intervention for cancer-related fatigue. The cancer rehabilitation team at Aurora Health Care’s Aurora M
Publikováno v:
Clinical Gastroenterology and Hepatology. 5:1080-1084
The Utah Population Database (UPDB) is unique; it links genealogy for over 2 million Utah individuals to a statewide Cancer Registry. We have investigated the familial nature of rectal cancer, considered independently from colon cancer.We estimated r